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Background: The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide. GDM and the risks
associated with GDM lead to increased health care costs and losses in productivity. The objective of this study is to
evaluate whether the FitFor2 exercise program during pregnancy is cost-effective from a societal perspective as
compared to standard care.
Methods: A randomised controlled trial (RCT) and simultaneous economic evaluation of the FitFor2 program were
conducted. Pregnant women at risk for GDM were randomised to an exercise program to prevent high maternal
blood glucose (n = 62) or to standard care (n = 59). The exercise program consisted of two sessions of aerobic and
strengthening exercises per week. Clinical outcome measures were maternal fasting blood glucose levels, insulin
sensitivity and infant birth weight. Quality of life was measured using the EuroQol 5-D and quality-adjusted life-
years (QALYs) were calculated. Resource utilization and sick leave data were collected by questionnaires. Data were
analysed according to the intention-to-treat principle. Missing data were imputed using multiple imputations.
Bootstrapping techniques estimated the uncertainty surrounding the cost differences and incremental cost-
effectiveness ratios.
Results: There were no statistically significant differences in any outcome measure. During pregnancy, total health
care costs and costs of productivity losses were statistically non-significant (mean difference €1308; 95%CI €-229 -
€3204). The cost-effectiveness analyses showed that the exercise program was not cost-effective in comparison to
the control group for blood glucose levels, insulin sensitivity, infant birth weight or QALYs.
Conclusion: The twice-weekly exercise program for pregnant women at risk for GDM evaluated in the present
study was not cost-effective compared to standard care. Based on these results, implementation of this exercise
program for the prevention of GDM cannot be recommended.
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The prevalence of gestational diabetes mellitus (GDM) is
increasing worldwide [1], paralleling the increase in type
2 diabetes (T2D) [2]. Approximately 1-14% of pregnant
women will develop GDM, depending on the population
and the diagnostic procedure [3]. Risk factors for GDM
are obesity (BMI ≥ 25), personal history of GDM, glyco-
suria, and/or a strong family history of diabetes. The
presence of GDM is associated with an increased mater-
nal risk for other pregnancy-related complications (pree-
clampsia, postpartum haemorrhage, caesarean section),
and with an increased risk for developing T2D after
pregnancy [4]. GDM also puts the infant at risk, since it
is associated with an increased risk for macrosomia,
jaundice and birth trauma [4]. Later in life, children
whose mothers had GDM, have an increased risk of
obesity, abnormal glucose tolerance, and T2D [4,5].
GDM and the risks associated with GDM lead to
increased health care costs and productivity losses [6].
Therefore, the prevention of high blood glucose during
pregnancy has become an important goal.
To prevent high blood glucose during pregnancy, there
are various preventive strategies available, such as redu-
cing a mother’s overweight and obesity, limiting gesta-
tional weight gain, improving diet and exercise
behaviour as well as various drug therapies with glucose-
lowering agents [7-10].
The effects of an exercise program (FitFor2) during
pregnancy for women at risk for GDM were evaluated in
a randomised controlled trial and have been reported
elsewhere [11]. In short, no statistically significant effects
of the intervention were found on maternal glucose, in-
sulin sensitivity or the infant’s birth weight compared to
the control group. However, although there were no
effects on clinical outcomes, the FitFor2 exercise pro-
gram may be a cost-effective intervention to prevent
high maternal blood glucose during pregnancy. To our
knowledge, no studies have been published on the cost-
effectiveness (CE) of such an intervention; therefore, in
this paper we report on the cost-effectiveness the pro-
gram in comparison to standard care.
Methods
Study design
The economic evaluation was conducted during a ran-
domised controlled trial (RCT) of the FitFor2 exercise
program for pregnant women at risk for GDM. The
protocol was approved by the Medical Ethics Committee
of the VU University Medical Centre, Amsterdam, the
Netherlands. Written informed consent was obtained
from all participants. Participants were followed from
15 weeks of pregnancy till 12 weeks postpartum. More
details about study design and methods of this RCT have
been described elsewhere [12].Participant recruitment
Recruitment took place in five hospitals and 20 midwif-
ery practices in the Netherlands, between November
2007 and April 2010. Participants were pregnant women
at increased risk for GDM. Women were considered to
be at increased risk for GDM if they were overweight
(BMI ≥ 25) and had at least one of the three following
characteristics: 1) history of macrosomia (offspring with
a birth weight above the 97th percentile of gestational
age), 2) history of GDM, or 3) first-grade relative with
diabetes mellitus type 2 or if they were obese (BMI ≥ 30).
Exclusion criteria included recruitment after 20 weeks of
gestation; age less than 18 years; inadequate knowledge
of the Dutch language; diagnosed with (gestational) dia-
betes mellitus before randomisation (fasting glucose
>6.0 mmol/l); hypertension; alcohol abuse; drug abuse;
use of medication that affects insulin secretion or insulin
sensitivity; serious pulmonary, cardiac, hepatic or renal
impairment; malignant disease; serious mental or phys-
ical impairment that made understanding or implemen-
tation of the study protocol/aim difficult.
Randomisation and blinding
Eligible women were randomised into the intervention
or control group. Randomisation was stratified for the
hospital where participants were offered the exercise
program. Within each stratum, block randomisation
with blocks of four was used to ensure that each group
consisted of an equal number of participants. The re-
searcher, patients, healthcare providers and research as-
sistant were not blinded for allocation after
randomisation due to the nature of the intervention. All
outcome measures were assessed by independent re-
search assistants who were unaware of group allocation.
Intervention
Women in the intervention group participated an exer-
cise program twice weekly in a group during the
remaining duration of their pregnancy. Each exercise
session lasted for 60 minutes. The exercise sessions con-
sisted of aerobic and strength exercises that help to con-
trol blood glucose levels. The training intensity was
carefully and individually controlled. All exercise ses-
sions were completed under the guidance and supervi-
sion of a specifically trained physiotherapist, and took
place in the Department of Physiotherapy of the partici-
pating hospitals. Details of the exercise program were
described previously by Oostdam et al. [12].
Women in the control group were not offered an exer-
cise program and received standard care from obstetri-
cians and/or midwives. The primary task of the Dutch
midwife is to closely follow the health status of the preg-
nant woman and her unborn child. Midwifes see their
clients on average 13 times during pregnancy on an
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women receive the same care as healthy-weight women.
The control group was followed throughout the entire
pregnancy period.Outcomes/effects
Outcome measures were maternal fasting blood glucose,
insulin sensitivity, infant birth weight, and quality-
adjusted life years (QALYs). Outcomes were assessed at
baseline (approximately 15 weeks of pregnancy), 24 and
32 weeks of pregnancy by laboratory tests and self-
administered questionnaires.
Maternal fasting blood was drawn from the antecubital
vein after the participant had fasted for at least 10 hours.
In this blood sample, glucose and insulin were mea-
sured. For insulin sensitivity, the homeostasis model as-
sessment (HOMA) was calculated.
In the Netherlands, birth weight is routinely measured
and recorded by the obstetrician, midwife or the nurse
at delivery. Birth weight was obtained from a question-
naire filled out by the women 12 weeks postpartum.
Health-related quality of life was measured using the
EuroQol-5D questionnaire [13]. Utilities were deter-
mined using the Dutch tariff [14]. Quality-adjusted life
years (QALYs) were calculated by multiplying the util-
ities by the time spent in a given health state. Transi-
tions between health states were linearly interpolated.Cost data collection and valuation
The economic evaluation was conducted from a societal
perspective. Resource utilisation was assessed during
pregnancy with three questionnaires at 15-, 24-, and 32-
weeks of pregnancy. Direct costs included the costs of
visits to healthcare providers, medication, and informal
care. Indirect costs were costs related to sick leave. Costs
of delivery were assessed using a questionnaire 12 weeks
postpartum and were included in the direct costs.
Costs were reported in Euros and the index year was
2009 (this was the year that most data were collected).
Costs were calculated by multiplying the respective units
of resource use by standard costs according to Dutch
Manual for Costing [15]. For visits to care providers for
whom standard cost prices were not available, prices
according to professional organisations were used. Medi-
cation was valued using unit prices published by Royal
Dutch Society for Pharmacy [16]. Costs of absenteeism
from paid work were calculated using The Friction Cost
Method (FCM). The FCM assumes that costs are limited
to the period necessary to replace a sick worker, the fric-
tion period. A friction period of 154 calendar days and
an elasticity of 0.8 were used. The number of sick leave
hours was multiplied by the cost of productivity loss per
hour, based on age and gender.Data analysis
A power calculation was done for the primary outcome
measure of maternal fasting glucose. It was determined
that adequate power (>0.80) and a 5% significance level
would be achieved with 80 pregnant women in both
groups. The power calculation allowed for a 20% drop-
out rate.
The economic evaluation was performed according to
the intention-to-treat principle. Due to the considerable
amount of missing follow-up data, missing data were
imputed using multiple imputation (MI) based on Multi-
variate Imputation by Chained Equations (MICE) [17].
The MI procedure was performed in SPSS 18.0, in which
five complete data sets were generated. Using Rubin’s
rules, effects and costs from the five complete data sets
were pooled [18].
Participants with high blood glucose (>6.0 mmol/l) at
baseline (n = 4) and a twin pregnancy (n = 1) were
excluded from the analyses, because they did not fulfil
the inclusion criteria. Insulin levels that were out-of-
range, and therefore very unlikely, were coded as miss-
ing and subsequently imputed (n = 7).
The incremental cost-effectiveness ratio (ICER) is
defined as the ratio of the difference in costs and the dif-
ference in effects between the intervention and standard
care. ICERs were calculated for maternal fasting blood
glucose, insulin sensitivity, infant birth weight and
QALYs. The ICER indicates the additional investment
needed to gain one additional unit of effect. For the out-
come infant birth weight, the cost-effectiveness analysis
was done with total societal costs including delivery
costs.
Non-parametric bootstrapping with 5000 replications
was used to estimate “approximate bootstrap confidence”
(ABC) intervals around cost differences [19]. Bootstrapping
was also used to estimate the uncertainty surrounding the
incremental cost-effectiveness and cost-utility ratios (5000
replications). The bootstrapped cost-effect pairs were plot-
ted on a cost-effectiveness plane (CE plane) [20]. The CE
plane shows the difference in effect on the x-axis and the
difference in costs on the y-axis. Cost-effectiveness accept-
ability curves (CEA curves) were also estimated. CEA
curves show the probability that the intervention is cost-
effective in comparison with the control treatment for a
range of ceiling ratios. The ceiling ratio is defined as the
amount of money society is willing to pay to gain one unit
of effect [21].
Data processing was performed in SPSS 15.0. The
cost-effectiveness analyses were conducted in R.Sensitivity analysis
In a secondary analysis, the Human Capital Approach
(HCA) was used to estimate costs due to sick leave. In
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the FCA, nor is elasticity considered.Results
Participants
A total of 425 women were invited to participate in the
study of whom 121 women at risk for GDM were rando-
mised (59 usual care group and 62 intervention group).
101 participants completed the baseline measurement
and at least one follow-up measurement. The flow of the
participants has been reported elsewhere [12]. The base-
line characteristics of the study population are presented
in Table 1. No significant differences were found be-
tween the control and intervention group for any of the
variables.
Complete healthcare cost data during pregnancy were
available for 80 participants. At baseline, women with
complete cost follow-up had a significantly lower pregravid
BMI (mean BMI 32.9) than women without complete costTable 1 Baseline characteristics
Maternal
characteristics
Standard care
Group
Intervention
Group
P value
Means ± SD
n= 52
Means ± SD
n= 49
Independent
t-test
Age, years 30.1 ± 4.5 30.8 ± 5.2 0.481
BMI pp¥, kg/m2 33.9 ± 5.6 33.0 ± 3.7 0.378
Baseline glucose,
mmol/l
4.8 ± 0.5 4.7 ± 0.4 0.514
Baseline insulin
sensitivity
0.07 ± 0.06 0.08 ± 0.04 0.588
Baseline utility 0.81 ± 0.18 0.83 ± 0.22 0.605
% (n) % (n) Chi-Square
Test
Parity 0.281
•Nulliparous 28.0 (14) 38.3 (18)
•Multiparous 72.0 (36) 61.7 (29)
Race/ethnicity 0.600
•White/Caucasian 50.0 (25) 44.7 (21)
•Non-Caucasian 50.0 (25) 55.3 (26)
Educational level 0.805
•Lower 34.7 (17) 34.0 (16)
•Middle 34.7 (17) 40.4 (19)
•Higher 30.6 (15) 25.5 (12)
Employment status 0.282
•Employed 70.0 (35) 59.6 (28)
•Unemployed 30.0 (15) 40.4 (19)
Continuous variables (presented as means ± SDs) were analyzed by using an
independent t-test; categorical variables (presented as percentages (n values))
were analyzed by using a Chi-Square test.
¥BMI pp: pre-pregnancy BMI, based on self-reported weight and height.follow-up (mean BMI 35.8). For cases without complete
data, missing data were imputed.Healthcare utilisation
The following data were derived from the complete
cases only. Rates of healthcare utilisation were similar
between the groups; there were no statistically signifi-
cant between-group differences in terms of units of
healthcare consumption. During the pregnancies of
overweight women at risk for GDM, the top five most
commonly used healthcare services were: midwifery
(mean=8.5 , SD=5.4), gynaecology (mean=4 , SD=4.9),
paramedical professional (mean=2.3 , SD=5.5), general
practice (mean=2.2 , SD=2.5), hospitalisation (mean=0.7
, SD=3.4).Costs
Mean costs per group, mean cost differences and a 95%
CI for specific cost categories are presented in Table 2.
Total societal costs were €5034 (SE €744) in the inter-
vention group and €3725 (SE €462) in the control group.
However, this difference in total costs was not statisti-
cally significant. Direct costs were higher than indirect
costs. Delivery costs contributed most to total direct
costs, followed by hospitalisation and gynaecology costs.
Hospitalisation costs in the intervention group were
significantly higher than in the control group (€844; 95%
CI 298 ; 1955). This significant difference was caused by
one woman who spent a few weeks in hospital because
of her risk for a premature birth. No statistically signifi-
cant differences in costs were observed between the
intervention and control group for the other cost cat-
egories. Total costs in the intervention group were con-
siderably higher than in the control group, but this
difference was not statistically significant and was mainly
caused by the already mentioned prolonged hospitalisa-
tion in the intervention group.Effects
Table 3 shows that no statistically significant differences
were found between the intervention group and the control
group on maternal fasting blood glucose (−0.021; 95%CI
−0.22 ; 0.18), insulin sensitivity (HOMA) (0.006; 95%CI
−0.005 ; 0.017) at 32 weeks of gestation and birth weight
(156; 95%CI −83.9 ; 395.1). No statistically significant effect
on QALYs (−0.005; 95%CI −0.031 ; 0.021) was observed
either.
Compliance with the intervention was low, only a
small proportion of the women attended half of the
training sessions (16.3%). Many women stopped exercis-
ing during the course of their pregnancy because of
physical (pregnancy-related) limitations.
Table 2 Cost prices (€), multiply imputed and pooled mean (SE) total costs, and mean cost differences (95%CI) during
pregnancy for the intervention and the control group
Price €
(2009)
Intervention group
n= 49 € (SE)
Control group
n=52 € (SE)
Cost difference
€ (95%CI)
General practitioner* 28 43 (7.2) 44 (13.9) −1 (−35 ; 25)
Medical specialists* 72 31 (15) 19 (8.9) 12 (−16 ; 50)
Hospitalisation* 151 – 457 858 (392) 14 (9.7) 844 (298 ; 1955)
Occupational physician} 23.31 10 (4.3) 13 (4.1) −3 (−13 ; 10)
Mental health care* 65 – 103 26 (12.5) 22 (13.2) 4 (−33 ; 38)
Paramedical professionals*} 34.51 – 69.34 60 (23) 108 (36) −48 (−137 ; 24)
Dietician* 27 7 (2.3) 9 (4.1) −2.1 (−13 ; 6)
Midwife} 22.60 107 (11.4) 124 (10.7) −17 (−47 ; 14)
Obstetrician/Gynaecologist* 72 313 (51) 263 (47) 50 (−84 ; 186)
Delivery} 255.71 – 1047.31 1890 (242) 1568 (182) 322 (−244 ; 904)
Medications 8 (2.4) 6 (1.6) 1.9 (−3 ; 9)
Direct costs including delivery 3354 (491) 2189 (201) 1164 (286 ; 2431)
Direct costs excluding delivery 1463 (407) 622 (53) 842 (260 ; 1978)
Productivity loss FCA¥ 1455 (533) 1536 (433) −81 (−1306 ; 1375)
Productivity loss HCM¥ 1498 (578) 1536 (433) −38 (−1278 ; 1567)
Intervention† 21 225 (29) 0 225
Total costs including delivery (FCA) 5034 (744) 3725 (462) 1308 (−229 ; 3204)
Total costs excluding delivery (FCA) 3144 (666) 2157 (436) 986 (−424 ; 2668)
Abbreviations: €; Euros, SE; standard error, 95%CI; 95% confidence interval, FCA; friction cost approach, HCM; human capital method.
*Prices according to Dutch guidelines for costing.
}Prices according to professional organisation or health care provider.
¥Production loss per hour based on age and gender, obtained from the Dutch guidelines for costing.
†The cost price of the exercise program was €21 per session per participant.
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Figure 1 shows the CE plane for the intervention versus
control group for outcome of maternal fasting blood
glucose at 32 weeks of gestation. The ICER for the out-
come maternal fasting blood glucose was −46,971
(Table 3), meaning that to gain one point of improve-
ment in blood glucose in the intervention group com-
pared with the control group was associated with
€46,971 higher costs. This ICER is too high to allow for
meaningful interpretation. The CE plane for the out-
come maternal fasting blood glucose at 32 weeks of ges-
tation confirms the findings that there were no
significant differences in total costs or blood glucose
levels between the intervention and control group.
The CEA curve in Figure 1 shows that the maximum
probability that the intervention group is cost-effective
in comparison with the control group lies around 0.4.
However, to reach this probability, society should be
willing to pay a large amount of money (approximately
€110,000) for an extra unit of improvement in maternal
fasting blood glucose. The CE plane and ICER for the
outcome insulin sensitivity showed similar results as ma-
ternal fasting blood glucose (data not shown).The CE planes for outcomes birth weight and QALY
showed that most bootstrapped cost effect pairs were
situated in the northwest quadrant (84.7% and 58.4% re-
spectively) indicating that the intervention was less ef-
fective and more costly, but not statistically significantly
so.
Sensitivity analysis
Only one woman was absent from work from the begin-
ning of her pregnancy and exceeded the friction period.
Using the HCM, the costs of lost productivity were
higher than the FCA (Table 3). This resulted in larger
ICERs than in the main analysis, but the conclusion of
the study did not change.
Discussion
In the present study we evaluated the cost-effectiveness
of an exercise program in comparison with standard care
to prevent high blood glucose levels, insulin sensitivity
and high birth weight among pregnant women at risk
for GDM. There were no statistically significant differ-
ences in effects, costs of health care utilisation or prod-
uctivity losses between the intervention group and the
Table 3 Differences in pooled mean costs, effects (95%CI), and incremental cost-effect ratios (ICERs)
Analysis Sample size Outcome ΔC (95%CI) ΔE (95%CI) ICER Distribution CE plane
I C € NE SE SW NW
FCA 49 52 Fasting glucose 986 (−424 ; 2668) −0.021 (−0.22 ; 0.18) −46971 37.1 4.4 5.4 53.2
49 52 IS homa 986 (−424 ; 2668) 0.006 (−0.005 ; 0.017) 162995 11.4 1 8.9 78.7
49 52 QALY 986 (−424 ; 2668) −0.005 (−0.031 ; 0.021) −208558 31.4 5.4 4.7 58.4
49 52 Birth weight 1308 (−229 ; 3204) 156 (−83.9 ; 395.1) 8.4 9.4 0.2 5.6 84.7
HCM 49 52 Fasting glucose 1029 (−392 ; 2830) −0.021 (−0.22 ; 0.18) −49008 37.4 4.3 5.5 52.9
49 52 IS homa 1029 (−392 ; 2830) 0.006 (−0.005 ; 0.017) 170064 11.2 1 8.7 79.1
49 52 QALY 1029 (−392 ; 2830) −0.005 (−0.031 ; 0.021) −217602 31.7 5.4 4.5 58.5
49 52 Birth weight 1352 (−199 ; 3356) 156 (−83.9 ; 395.1) 8.7 9.5 0.2 5.9 84.3
Abbreviations: ΔC; costs intervention group-costs control group, ΔE; effects intervention group-effects control group, 95%CI; 95% confidence interval, ICER;
incremental cost-effectiveness ratio, CE; cost-effectiveness, I; intervention group, C; control group, €; Euros, FCA; friction cost approach, HCM; human capital
method.
NE; refers to the northeast quadrant of the CE plane, which indicates that the exercise program is more effective and more costly than the control group.
SE; refers to the southeast quadrant of the CE plane, which indicates that the exercise program is more effective and less costly than the control group.
SW; refers to the southwest quadrant of the CE plane, which indicates that the exercise program is less effective and less costly than the control group.
NW; refers to the northwest quadrant of the CE plane, which indicates that the exercise program is less effective and more costly than the control group.
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the exercise program was not cost-effective compared to
standard care for any of the included outcome measures.
To the best of our knowledge, our study was the
first to evaluate the cost-effectiveness of an interven-
tion to prevent GDM. A comparison with other inter-
vention studies, therefore, is not possible. However
literature has shown that costs for overweight or
obese pregnant women and women at risk for GDM
are higher than for women with normal weight [22-
24].
Kolu [22] evaluated frequency and costs of antenatal
health care visits related to risk of GDM. Visits to pri-
mary and special health care and costs of OGTT (oral
glucose tolerance test) were €1553 in women at risk for
GDM, which was more (10-41%) than the costs in the
non-risk group. Women diagnosed with GDM had more
antenatal health care visits than women without a con-
firmed diagnosis (17–18 visits versus 16 visits).
Galtier-Dereure [23,24] investigated the cost of pre-
natal care in women with pregravid overweight in
two separate studies. Both studies concluded that
overall costs and hospital duration were higher in
overweight women than in normal-weight women.
Mean duration of hospitalisation and overall costs
were strongly related to maternal prepregnancy
weight. However, no cost estimates were presented.
In our study, we cannot make a comparison with nor-
mal weight women or women not at risk for GDM. The
previous studies have not taken costs associated with a
loss of productivity into account, making comparisons
impossible. However, the high costs associated with hos-
pitalisation and delivery in our study are similar to the
above mentioned studies.Strengths and limitations
To the best of our knowledge, this was the first study to
evaluate the cost-effectiveness of an exercise program
for pregnant women at risk for GDM. An important
strength of the current study is that the economic evalu-
ation was conducted alongside a randomised controlled
trial, where the risk of bias is limited. Another strength
is that this was a pragmatic study, resembling clinical
practice as much as possible.
The study also has some limitations. The first limita-
tion is that the intervention used in our study had low
compliance and showed no significant effects on fasting
blood glucose, insulin, and birth weight. To examine the
effect of exercise on the prevention of GDM it is import-
ant to have a good rate of compliance with the interven-
tion. Perhaps with another type of intervention, such as
a counselling intervention, a better compliance and en-
gagement with physical activity and exercise can be
achieved for this group of obese pregnant women. An-
other limitation is the considerable loss to follow-up
data, which may have reduced the reliability of the
results. To account for this, missing values were imputed
by using the MICE procedure. Multiple imputation takes
into account the uncertainty associated with imputing
missing values and is recommended to impute missing
cost data [25]. However, missing values might have com-
promised validity of or findings. In addition, the RCT
was underpowered to detect cost differences, because
the power calculation was based on maternal fasting
blood glucose. Cost data usually follow a highly skewed
distribution, implying a need for larger sample sizes in
cost/effectiveness studies as compared to effectiveness
studies, [25] which may be considered unfeasible or even
unethical.
higher costs / less effects higher costs / more effects
lower costs / less effects lower costs / more effects
A
B
Figure 1 (A) CE plane and (B) CEA curve for outcome maternal fasting blood glucose (multiple imputed data).
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which may have introduced recall bias. However, this
method was used in both the intervention and control
group, so it is unlikely that it will have influenced our
results. Furthermore, van den Brink et al. showed that a
cost questionnaire with structured closed questions might
replace a cost diary for recall periods up to six months [26].Conclusion
The exercise program for pregnant women at risk for
GDM evaluated in the present study was not found to
be cost-effective compared to usual care to prevent high
blood glucose levels, insulin sensitivity and high infant
birth weight. Factors such as low compliance, and lack
of power may explain these results. We feel that other
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target group in physical activity and exercise. Further-
more, to reduce costs in women at risk for GDM, the
focus should be on interventions that may reduce deliv-
ery costs and productivity losses. Based on these results,
implementation of this exercise program in the preven-
tion of GDM cannot be recommended.
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